Horizon Therapeutics PLC (HZNP) Social Stream
Horizon Therapeutics Public Ltd Co (HZNP) Price Targets From Analysts
Use the tables below to see what analysts covering Horizon Therapeutics Public Ltd Co think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
HZNP's average price target has moved up $23.55 over the prior 43 weeks.
Over the past 49 weeks, HZNP's average upside potential has been 27.65%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
HZNP Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
HZNP's average broker recommendation rating improved by 0.48 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HZNP as an investment opportunity.
- In terms of how Horizon Therapeutics Public Ltd Co fares relative to all US stocks, note that its average analyst price target is higher than 648.19% of that group.
- Horizon Therapeutics Public Ltd Co's upside potential (average analyst target price relative to current price) is higher than 104.58% of Pharmaceutical Products stocks.
- In terms of how Horizon Therapeutics Public Ltd Co fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 642.3% of that group.
- In the context of Pharmaceutical Products stocks, Horizon Therapeutics Public Ltd Co's variance in analysts' estimates is lower than -122.54% of them.
Is HZNP a Buy, Hold or Sell? See the POWR Ratings now!